New York, USA – January 29, 2021 – Creative Biostructure, a biotech company specialized in providing cost-effective contract services related to structural biology and membrane protein technologies to both academia and biotech industries, now applies its expertise to the drug discovery process to effectively shorten the time required for drug discovery and facilitate the development of innovative therapeutics.
With four leading technology platforms in structural biology, including X-ray crystallography platforms, nuclear magnetic resonance (NMR) spectroscopy platforms, electron microscopy (EM) platforms and membrane protein screening platforms, as well as its flexible gene-to-structure pipeline, Creative Biostructure has helped customers in academic groups, biotechnology companies and pharmaceutical companies solve many challenging biomolecular structures. The company has an experienced team of experts who have accumulated a wealth of experience in the research fields of GPCRs, transporters, ion channels, enzymes, and viral targets.
Now, Creative Biostructure applies its expertise in structural biology and membrane proteins to the drug discovery process and has established several platforms including target-based structural biology platform, computer-aided drug design (CADD) platform, and fragment-based drug design (FBDD) platform for structure accelerated drug discovery. Moreover, MagHelix™ zebrafish screening platform was established for building disease models and screening novel drugs.
Based on the information on Creative Biostructure Drug Discovery, its solutions for structure-based drug discovery cover the full range of customers’ needs for early-stage drug discovery, including target protein structure research, lead discovery and optimization, structure-based biological drug discovery, and biosimilars structure characterization.
“With the goal to help accelerate the preclinical development of innovative drugs through structural insight, we decided to launch this new subsite. We guarantee the confidentiality of customer project data and does not lay claim to any results from customers’ projects nor any intellectual property (IP) belonging to customers.” Commented Joanna, the chief marketing staff at Creative Biostructure.
To get a whole view about the services provided by Creative Biostructure Drug Discovery, please visit https://drug-discovery.creative-biostructure.com.